OncoGene Colon
Delivery time
No especificado
Sample
No especificado
845,25€
This is a genetic panel for the detection of point mutations in the RAS gene family, which is mutated in 50% of patients with colorectal cancer. The potential of these genes as therapeutic targets or prognostic markers makes this panel a key tool for selecting the best treatment for the patient. It includes mutation analysis in: KRAS (exons 2, 3, 4), NRAS (exons 2, 3, 4), and BRAF (exons 11, 15). The sample must be a surgical specimen of the tumor in an FFPE block. The blocks sent are returned to the center of origin once the test is completed.
Other tests
NGS-SEQ+CNVs - POLYPOSIUM SYNDROME-COLORECTAL CANCER
510,00€
NGS-SEQ+CNVs - SLE-LIKE SYNDROME
520,00€
NGS-SEQ+CNVs - IMMUNODEFICIENCY SYNDROMES
650,00€